JP2025019061A5 - - Google Patents

Info

Publication number
JP2025019061A5
JP2025019061A5 JP2024181817A JP2024181817A JP2025019061A5 JP 2025019061 A5 JP2025019061 A5 JP 2025019061A5 JP 2024181817 A JP2024181817 A JP 2024181817A JP 2024181817 A JP2024181817 A JP 2024181817A JP 2025019061 A5 JP2025019061 A5 JP 2025019061A5
Authority
JP
Japan
Prior art keywords
sample
level
infection
proadm
surgery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024181817A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025019061A (ja
Filing date
Publication date
Priority claimed from PCT/EP2020/054652 external-priority patent/WO2020169819A1/en
Application filed filed Critical
Publication of JP2025019061A publication Critical patent/JP2025019061A/ja
Publication of JP2025019061A5 publication Critical patent/JP2025019061A5/ja
Pending legal-status Critical Current

Links

JP2024181817A 2019-02-21 2024-10-17 術後有害事象の診断または予後 Pending JP2025019061A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP19020082 2019-02-21
EP19020082.4 2019-02-21
PCT/EP2020/054652 WO2020169819A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events
JP2021548207A JP2022521390A (ja) 2019-02-21 2020-02-21 術後有害事象の診断または予後

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021548207A Division JP2022521390A (ja) 2019-02-21 2020-02-21 術後有害事象の診断または予後

Publications (2)

Publication Number Publication Date
JP2025019061A JP2025019061A (ja) 2025-02-06
JP2025019061A5 true JP2025019061A5 (https=) 2025-08-18

Family

ID=65529223

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021548207A Pending JP2022521390A (ja) 2019-02-21 2020-02-21 術後有害事象の診断または予後
JP2024181817A Pending JP2025019061A (ja) 2019-02-21 2024-10-17 術後有害事象の診断または予後

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021548207A Pending JP2022521390A (ja) 2019-02-21 2020-02-21 術後有害事象の診断または予後

Country Status (7)

Country Link
US (1) US20220187313A1 (https=)
EP (1) EP3928099A1 (https=)
JP (2) JP2022521390A (https=)
CN (1) CN113424065A (https=)
BR (1) BR112021016597A2 (https=)
CA (2) CA3295270A1 (https=)
WO (1) WO2020169819A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240221958A1 (en) * 2021-04-30 2024-07-04 Roche Diagnostics Operations, Inc. Pct marker panels for early detection of sepsis
WO2022229438A2 (en) * 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Il6 marker panels for early detection of sepsis
EP4351636A4 (en) * 2021-06-02 2025-04-23 Washington University Systems and methods for multimodal analysis of surgical drain fluid using interchangeable and customizable nucleic acid based tests
US12152280B2 (en) 2021-09-20 2024-11-26 Droplet Biosciences, Inc. Drain fluid for diagnostics
JP2023111774A (ja) * 2022-01-31 2023-08-10 国立研究開発法人国立循環器病研究センター 再灌流療法の適用を決定するバイオマーカー
KR20250077078A (ko) * 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심장 트로포닌 수치를 예측하기 위한 방법 및 장치
KR20250077079A (ko) 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심근 손상을 예측하기 위한 방법 및 장치
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement
KR102750097B1 (ko) * 2024-07-29 2025-01-03 가천대학교 산학협력단 심혈관 시술 이후 환자의 합병증 예측 및 추적 관리 시스템 및 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
ATE312351T1 (de) 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
US9012151B2 (en) * 2006-11-09 2015-04-21 B.R.A.H.M.S. Gmbh Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
JP5711131B2 (ja) * 2008-10-07 2015-04-30 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最初の有害事象の予測のためのバイオマーカー
WO2014018464A1 (en) * 2012-07-23 2014-01-30 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of sepsis
GB201402293D0 (en) * 2014-02-11 2014-03-26 Secr Defence Biomarker signatures for the prediction of onset of sepsis
ES2944613T3 (es) * 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso
JP6855118B2 (ja) * 2017-03-14 2021-04-07 東ソー株式会社 全身状態の良不良を評価するための情報を提供する方法及び測定試薬
EP3438668A1 (en) * 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections

Similar Documents

Publication Publication Date Title
JP2025019061A5 (https=)
Eagle et al. Dipyridamole-thallium scanning in patients undergoing vascular surgery: optimizing preoperative evaluation of cardiac risk
Iseki Factors influencing the development of end-stage renal disease
Butler et al. Causes of death in diarrhoeal diseases after rehydration therapy: an autopsy study of 140 patients in Bangladesh
Icard et al. Utility of C-reactive protein measurements for empyema diagnosis after pneumonectomy
Gaurav et al. Effectiveness of Mannheim’s Peritonitis Index in Patients With Peritonitis Secondary to Hollow Viscus Perforation in a Tertiary Care Hospital in Jharkhand, India
Bartels et al. The significance of anticardiolipin antibodies and anti-heart muscle antibodies for the diagnosis of postpericardiotomy syndrome
Ogawa et al. Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients comparison of electrocardiography, chest radiography and echocardiography
Berden et al. Mechanism and extent of myocardial injury associated with out-of-hospital cardiac arrest
JPWO2020169819A5 (https=)
JP2021534385A5 (https=)
Senoo et al. Relationship Between Body Mass Index and Incidence of Atrial Fibrillation in Young Japanese Men―The Nishimura Health Survey―
RU2684363C1 (ru) Способ прогнозирования риска развития послеоперационных осложнений стенозов внутренних сонных артерий
RU2312589C1 (ru) Способ оценки риска развития неблагоприятных кардиальных событий у больных с острым коронарным синдромом без подъема сегмента st
RU2355300C2 (ru) Способ прогнозирования возникновения пароксизмальной фибрилляции предсердий после операции коронарного шунтирования
Waghmare A descriptive observational study of assessment of severity of peritonitis using Mannheim Peritonitis Index
MÆLAND et al. Predicting Long‐term Mortality after a Myocardial Infarction from Routine Hospital Data
Aksakal et al. Electrocardiographic Evaluation of Patients with Crimean-Congo Hemorrhagic Fever
JP7629000B2 (ja) 心筋炎の発症またはそのリスクを判定する方法
RU2610922C1 (ru) Способ стратификации риска возникновения фибрилляции предсердий у больных с кардиоваскулярной патологией после проведения реконструктивных кардиохирургических операций
Ugur et al. Evaluation of the Clinical, Laboratory and Radiology Findings and Treatment Methods of Children with Acute Bronchiolitis: Experience of a Tertiary Center.
Acar et al. Case report: Coexistence of takotsubo syndrome and severe mononeuritis multiplex in rheumatoid vasculitis.
RU2725850C1 (ru) Способ ранней диагностики хронического тубулоинтерстициального повреждения почек у пациентов с анкилозирующим спондилитом
Maggio et al. Preoperative evaluation in non-cardiac surgery: Cardiac risk assessment
Anwar et al. Incidence and associated risk factors of contrast induced nephropathy in diabetes and non diabetic patients